cancer
Youth Health
User Blocked by Social Media Platform
Cancer mortality rates gap between Black and White individuals narrowed since 1990s, driven by lung and prostate cancer improvement.
Food Access
Service Apologizes for Blocking Users
Updated trial data shows the ALK inhibitor lorlatinib achieves record progression-free survival for lung cancer, potentially changing treatment guidelines.